Article
Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2'-deoxyuridine-5'-monophosphate on ABCC11 in silico models.
BMC structural biology - 6 May 2013
Honorat Mylène, Terreux Raphaël, Falson Pierre, Di Pietro Attilio, Dumontet Charles, Payen Lea
Abstract excerpt
BACKGROUND: The Multidrug Resistance Protein ABCC11/MRP8 is expressed in physiological barriers and tumor breast tissues in which it secretes various substrates including cGMP (cyclic guanosine monophosphate) and 5FdUMP (5-fluoro-2'-deoxyuridine-5'-monophosphate), the active metabolite of the anticancer drug 5-FluoroUracil (frequently included to anticancer therapy).Previously, we described that ABCC11 high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
